Skip to main content

Table 4 Adjusted hazard ratios of diabetes incidence comparing individual angiotensin receptor blocker with losartan among different subgroups

From: Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study

  Valsartan Irbesartan Candesartan Telmisartan Olmesartan
Age < 70 years 1.01 (0.99-1.04) 1.01 (0.98-1.04) 1.02 (0.98-1.06) 1.01 (0.97-1.05) 1.07 (1.02-1.12)
Age  70 years 1.00 (0.96-1.04) 0.95 (0.91-0.99) 0.92 (0.86-0.99) 0.95 (0.89-1.01) 1.09 (1.01-1.18)
Men 0.99 (0.97-1.02) 0.98 (0.95-1.01) 1.00 (0.95-1.05) 0.98 (0.94-1.03) 1.08 (1.02-1.14)
Women 1.03 (1.00-1.06) 1.01 (0.97-1.04) 0.99 (0.94-1.04) 1.00 (0.96-1.05) 1.06 (1.00-1.13)
With hypertension 1.01 (0.99-1.03) 0.98 (0.96-1.01) 0.99 (0.95-1.02) 0.98 (0.95-1.02) 1.07 (1.02-1.11)
Without hypertension 1.02 (0.96-1.08) 1.07 (0.99-1.15) 1.03 (0.93-1.14) 1.09 (0.97-1.22) 1.13 (0.98-1.31)